Evidence map›Paper›PMID 33390686›Full record

ArticleIEEE journal of selected topics in quantum electronics : a publication of the IEEE Lasers and Electro-optics Society

Optofluidic Amplification-free Multiplex Detection of Viral Hemorrhagic Fevers.

Alexandra Stambaugh, Matthew A Stott, Gopikrishnan G Meena, Manasi Tamhankar, Ricardo Carrion, Jean L Patterson, Aaron R Hawkins, Holger Schmidt

Open access · greenAbstract read
In one paragraph

Article in IEEE journal of selected topics in quantum electronics : a publication of the IEEE Lasers and Electro-optics Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Optofluidic multiplex detection of single SARS-CoV-2 and influenza A antigens using a novel bright fluorescent probe assay.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Alexandra StambaughSchool of Engineering, University of California Santa Cruz, Santa Cruz, CA 95064 USA.
Matthew A StottDepartment of Electrical and Computer Engineering, Brigham Young University, Provo UT 84602 USA.
Gopikrishnan G MeenaSchool of Engineering, University of California Santa Cruz, Santa Cruz, CA 95064 USA.
Manasi TamhankarDepartment of Virology and Immunology, Texas Biomedical Research Institute, San Antonio, TX 78227 USA.
Ricardo CarrionDepartment of Virology and Immunology, Texas Biomedical Research Institute, San Antonio, TX 78227 USA.
Jean L PattersonDepartment of Virology and Immunology, Texas Biomedical Research Institute, San Antonio, TX 78227 USA.
Aaron R HawkinsDepartment of Electrical and Computer Engineering, Brigham Young University, Provo UT 84602 USA.
Holger SchmidtSchool of Engineering, University of California Santa Cruz, Santa Cruz, CA 95064 USA.
Texas Biomedical Research Institute · USUniversity of California, Santa Cruz · USBrigham Young University · US

Funding

The Southwest National Primate Research Center Supplement- Infrastructure improvements of ABSL2 holding areasP51OD011133 · OD · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI Larry S. Schlesinger · 2012 to 2026
$129.7M
Multiplexed, Non-Amplified, Nucleic Acid-Based Identification of Multidrug Resistant Pathogens Using an Integrated Optofluidic PlatformR01AI116989 · NIAID · BRIGHAM YOUNG UNIVERSITY · PI HAWKINS, AARON R., PITT, WILLIAM G · 2015 to 2019
$5.4M
Hybrid integrated molecular analysis (HIMAS) for point-of-care diagnosticsR33AI100229 · NIAID · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI SCHMIDT, HOLGER · 2014 to 2016
$1.7M
NIAID NIH HHS R01 AI116989NIAID NIH HHS R33 AI100229NIH HHS P51 OD011133
6 · The paper itself

Abstract

Infectious disease outbreaks such as Ebola and other Viral Hemorrhagic Fevers (VHF) require low-complexity, specific, and differentiated diagnostics as illustrated by the recent outbreak in the Democratic Republic of Congo. Here, we describe amplification-free spectrally multiplex detection of four different VHF total RNA samples using multi-spot excitation on a multimode interference waveguide platform along with combinatorial fluorescence labeling of target nucleic acids. In these experiments, we observed an average of 8-fold greater fluorescence signal amplitudes for the Ebola total RNA sample compared to three other total RNA samples: Lake Victoria Marburg Virus, Ravn Marburg Virus, and Crimean-Congo Hemorrhagic Fever. We have attributed this amplitude amplification to an increased amount of RNA during synthesis of soluble glycoprotein in infection. This hypothesis is confirmed by single molecule detection of the total RNA sample after heat-activated release from the carrier microbeads. From these experiments, we observed at least a 5.3x higher RNA mass loading on the Ebola carrier microbeads compared to the Lake Victoria Marburg carrier microbeads, which is consistent with the known production of soluble glycoprotein during infection.

Indexed as

BiophotonicsFluorescenceOptofluidicsWaveguidesWavelength Division Multiplexing

Identifiers

PMID33390686
PMCPMC7774596
OpenAlexW3091927314

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.